$47.3 Million is the total value of HealthInvest Partners AB's 10 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTMD | UTAH MED PRODS INC | $7,337,000 | -0.7% | 86,000 | 0.0% | 15.50% | -9.0% | |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $6,967,000 | +105.6% | 98,000 | +122.7% | 14.72% | +88.4% |
| GILD | Buy | GILEAD SCIENCES INC | $6,477,000 | +80.7% | 105,000 | +81.0% | 13.68% | +65.5% |
| CI | Buy | CIGNA CORP NEW | $4,717,000 | +27.9% | 17,000 | +21.4% | 9.96% | +17.2% |
| KMPH | Buy | KEMPHARM INC | $4,680,000 | +56.6% | 750,000 | +11.9% | 9.89% | +43.5% |
| CAH | New | CARDINAL HEALTH INC | $4,668,000 | – | 70,000 | +100.0% | 9.86% | – |
| MCK | Buy | MCKESSON CORP | $4,418,000 | +35.4% | 13,000 | +30.0% | 9.33% | +24.1% |
| VTRS | Buy | VIATRIS INC | $4,090,000 | +26.0% | 480,000 | +54.8% | 8.64% | +15.4% |
| OPNT | OPIANT PHARMACEUTICALS INC | $2,258,000 | -10.3% | 210,000 | 0.0% | 4.77% | -17.8% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $1,730,000 | -25.2% | 230,000 | 0.0% | 3.65% | -31.4% | |
| BIIB | Exit | BIOGEN INC | $0 | – | -16,000 | -100.0% | -7.52% | – |
| HRMY | Exit | HARMONY BIOSCIENCES HLDGS IN | $0 | – | -76,000 | -100.0% | -8.54% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -1,265,000 | -100.0% | -9.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-10-21
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.